BR vs KROS · P/E 16, rev $7.48B vs rev $32.0K
Broadridge Financial Solutions Inc (BR) versus Keros Therapeutics Inc (KROS) — a side-by-side from cached financials, not a winner call.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Keros Therapeutics Inc (KROS) is a biotechnology company listed on US.
Latest reported BR revenue for 2026-06-30 was $7.48B. Net income was $1.12B. Revenue was up 8.5% from 2025-06-30 to 2026-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Latest reported KROS revenue for 2026-06-30 was $32.0K. Net income was -$52.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. KROS currently screens at market cap $208.8M.
BR currently screens at market cap $17.65B and trailing P/E 16.3. KROS currently screens at market cap $208.8M.
Not investment advice. Open the BR and KROS stock pages for the full models.
Not investment advice.